# NPTEL Intellectual Property Week 02 Assignment Answers

Are you looking for NPTEL Intellectual Property Week 02 Assignment Answers? This repository will help you find your answers and solutions for Week 02 of the **Intellectual Property** course. We provide detailed solutions to help you complete your assignments efficiently.

## _Intellectual Property Week 2 Nptel Assignment Answers 2025 (Jan-Apr 2025)_

***

1\. The turnover of a startup should not exceed

- 25 crores within the 5 years period
- 100 crores within the 10 years period
- 20 crores within the 5 years period
- 20 crores within the 7 years period

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

2\. Novartis patent was for-

- Beta crystalline form of Imatinib Mesylate.
- Alpha crystalline form of Imatinib Mesylate.
- Gamma crystalline form of Imatinib Mesylate.
- None of the above

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

3\. The ability of mass duplication in intangible assets exists because of the trait:

- Sunkenness
- Scalability
- Liquidity
- None of the above

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

4\. Definition of start-Up is in

- Rule 2 f(b)
- Rule 4 a
- Rule 20
- Rule 16

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

5. Statement 1: An entity shall cease to be a startup on completion of 7 years from the date of its incorporation/registration.\
Statement 2: In respect of Startups in the biotechnology sector, an entity shall cease to be a Startup on completion of 7 years from the date of its incorporation/registration.

- Statement 1 is True and Statement 2 is False
- Statement 1 is False and Statement 2 is True
- Both Statement 1 and 2 are True
- Both Statement 1 and 2 are False

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

6. Statement 1: “Synergies” in intangibility refers to the fact that the benefit of an intangible asset may accrue on others.\
Statement 2: Strong IP rights increase investment and reduce synergies and leads to Patent thickets.

- Statement 1 is True and Statement 2 is False
- Statement 1 is False and Statement 2 is True
- Both Statement 1 and 2 are True
- Both Statement 1 and 2 are False

[****See also**  **Intellectual Property Week 1 Nptel Assignment Answers 2025****](https://progiez.com/intellectual-property-week-1-nptel-assignment-answers)

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

7\. The ground pertaining to the rejection of the Novartis patent is:

- Not an invention under section 3(d)
- Non-disclosure of biological material
- No-Prior art found
- Lack of inventive step

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

8\. FRAND license term includes:

- Fair and Reasonable terms
- Non-discriminatory
- Limitation of technology usage
- None of the above

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

9\. Which of the following falls under intangible investments?

- New technological ideas
- New Product designs
- New Business Models
- Ownership of land as asset

****[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)****

***

10\. The Novartis standard established after the judgment is/are:

- Identifying the new form of the known substance
- Comparing the pharmacological properties of the known substance with new form of the known substance
- Provide comparative material on enhanced efficacy
- Lack of inventive step

**[**View Answer**](https://my.progiez.com/courses/intellectual-property-nptel-quiz-answers/)**

***

Intellectual Property Week 2 Nptel Assignment Answers 2025

For answers to others Nptel courses, please refer to this link: [NPTEL Assignment](https://progiez.com/nptel-assignment-answers)
